Practical Use and Risk of Modafinil, a Novel Waking Drug
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Modafinil is a waking drug prescribed to narcolepsy patients, but its usage among healthy individuals is increasing to enhance their alertness or to mitigate fatigue. This study was conducted to investigate practical use and toxic effects on neuro-immune interaction of modafinil. METHODS: This study reviewed the significance of psychoactive drugs, and discussed the benefits and risks of the application of modafinil, which seems to be ideal as an anti-psychotic or anti-fatigue agent. RESULTS: Modafinil is known to have less or no adverse effects than those found in traditional psychostimulants such as amphetamine, methylphenidate or cocaine. It can be applied as an anti-psychotic or anti-fatigue agent. However, the waking mechanism of modafinil is yet to be fully revealed. Recent studies reported that modafinil may be subject to abuse and addiction. In addition prolonged sleeplessness induces stress responses and impairs immune function. CONCLUSIONS: Modafinil can be used by anyone, who wishes to work late, stay awake, enhance their cognitive reactions, or brighten their moods. Users may already be under a great level of stress, i.e. cancer patients or soldiers in a battle field. A psychoneuroimmunological approach is thus needed to investigate the multi-functional effects of modafinil.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 3×
“Chang FC, Opp MR. Corticotropin-releasing hormone (CRH) as a regulator of waking.”
BackgroundNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 2×
“The disruption of circadian rhythm and sleep control may influence the neuro-immune circuits [32,33].”
BackgroundModafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713 · cited 2×
“There is substantial evidence that modafinil, just like other addictive drugs, is sensitive to dopamine signaling in the brain [30,45-47].”
BackgroundFatigue Countermeasures in Aviation
Caldwell, J. A., Mallis, M. M., Caldwell, J. L., Paul, M. A., Miller, J. C., & Neri, D. F. (2009) · Aviation, Space, and Environmental Medicine · doi:10.3357/asem.2435.2009 · Cited by 295 · cited 5×
“Modafinil has also been tried on disease-related fatigue, attention-deficit disorder, Alzheimer’s disease, age-related memory decline, depression, idiopathic hypersomnia, cognitive impairment in schizophrenia, myotonic dystrophy, post-anaesthesia grogginess, everyday cat-napping, and jet-lag treatment [2, 8-12].”
BackgroundInfluentialCorticotropin-releasing hormone (CRH) as a regulator of waking
Chang, F.-C., & Opp, M. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00024-0 · Cited by 99 · cited 3×
“Chang FC, Opp MR. Corticotropin-releasing hormone (CRH) as a regulator of waking.”
BackgroundHuck, N. O., Mcbride, S. A., Kendall, A. P., Grugle, N. L., & Killgore, W. D. S. (2008) · International Journal of Neuroscience · doi:10.1080/00207450601125907 · Cited by 69 · cited 3×
“Modafinil is also of a high interest to the US military for enhancing alertness and reducing battle fatigue [8,13,14].”
BackgroundModafinil elicits sympathomedullary activation
Taneja, I., Diedrich, A., Black, B. K., Byrne, D. W., Paranjape, S. Y., & Robertson, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000158267.66763.63 · Cited by 68 · cited 1×
“Alertness-enhancing effect of modafinil may affect the autonomic nervous system in the periphery [61,62].”
BackgroundBehavioral and subjective effects of D-amphetamine and modafinil in healthy adults.
Makris, A. P., Rush, C. R., Frederich, R. C., Taylor, A. C., & Kelly, T. H. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.2.123 · Cited by 68
Adler, L. A., Weisler, R. H., Goodman, D. W., Hamdani, M., & Niebler, G. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05335pur · Cited by 42
Pharmacotherapy for Adult ADHD
Adler, L. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7129br5c · Cited by 14
Cited by
Muscle fatigue: general understanding and treatment
Wan, J.-J., Qin, Z., Wang, P.-Y., Sun, Y., & Liu, X. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.194 · Cited by 676
An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil
Murillo-Rodríguez, E., Barciela Veras, A., Barbosa Rocha, N., Budde, H., & Machado, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00374 · Cited by 91
A review on modafinil: the characteristics, function, and use in critical care
Hashemian, S. M., & Farhadi, T. (2020) · Journal of Drug Assessment · doi:10.1080/21556660.2020.1745209 · Cited by 30
Karila, L., Leroy, C., Dubol, M., Trichard, C., Mabondo, A., Marill, C., Dubois, A., Bordas, N., Martinot, J.-L., Reynaud, M., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.28 · Cited by 27
Metadata
- Authors
- Kim, D.
- Venue
- Environmental Health and Toxicology
- Published
- 2012-02-22
- Volume
- 27
- Pages
- e2012007
- ISSN
- 2233-6567 (ISSN-L)
- OpenAlex
- W2028618778
- Cited by
- 73
- References
- 10
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Practical Use and Risk of Modafinil, a Novel Waking Drug. https://app.cochat.ai/papers/10.5620/eht.2012.27.e2012007
- The paper
- Kim, D. (2012). Practical Use and Risk of Modafinil, a Novel Waking Drug. Environmental Health and Toxicology. https://doi.org/10.5620/eht.2012.27.e2012007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.